| Gene | Disease | Score gda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
0.300 | Biomarker | CTD_human | The consequent overexpression of Igf2 results in most of the symptoms of Beckwith-Wiedemann syndrome, including prenatal overgrowth, polyhydramnios, fetal and neonatal lethality, disproportionate organ overgrowth including tongue enlargement, and skeletal abnormalities. | 9349812 | 1997 |
||||||||
|
|
0.100 | CausalMutation | CLINVAR | Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants. | 29469822 | 2018 |
||||||||
|
|
0.100 | GeneticVariation | CLINVAR | Novel mutation in CNTNAP1 results in congenital hypomyelinating neuropathy. | 27668699 | 2017 |
||||||||
|
|
0.100 | GeneticVariation | CLINVAR | Phenotypic and molecular characterisation of CDK13-related congenital heart defects, dysmorphic facial features and intellectual developmental disorders. | 28807008 | 2017 |
||||||||
|
|
0.100 | GeneticVariation | CLINVAR | Biochemical characterization of novel germline BRAF and MEK mutations in cardio-facio-cutaneous syndrome. | 18413255 | 2008 |
||||||||
|
|
0.100 | CausalMutation | CLINVAR | Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. | 17603483 | 2007 |
||||||||
|
|
0.100 | CausalMutation | CLINVAR | Germline gain-of-function mutations in RAF1 cause Noonan syndrome. | 17603482 | 2007 |
||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO |